Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX)

Q: What does CUSIP 20454B104 represent in this 13F holders report?

CUSIP 20454B104 is the security identifier for CMPX - Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held CMPX - Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share in Q3 2022?

36 institutional investors reported CMPX - Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share for Q3 2022. Use the holders table for investor-level position and value details.

CUSIP: 20454B104

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 180,181,824
Total 13F shares: 63,858,418
Share change: +1,971,848
Total reported value: $145,631,000
Price per share: $2.28
Number of holders: 36
Value change: +$3,917,942
Number of buys: 18
Number of sells: 7

Quarterly Holders Quick Answers

What is CUSIP 20454B104?
CUSIP 20454B104 identifies CMPX - Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2022
Previous quarter: Q2 2022

Recent filing periods for CUSIP 20454B104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CMPX - Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	12%	21,960,850	$58,196,000	—	30 Jun 2022	13F
FMR LLC	13F	Company	3.8%	6,872,414	$18,212,000	—	30 Jun 2022	13F
Rock Springs Capital Management LP	13F	Company	3%	5,328,088	$14,119,000	—	30 Jun 2022	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	2.4%	4,406,600	$11,677,000	—	30 Jun 2022	13F
Foresite Capital Management V, LLC	13F	Company	2.4%	4,400,000	$11,660,000	—	30 Jun 2022	13F
JANUS HENDERSON GROUP PLC	13F	Company	1.9%	3,347,171	$8,803,000	—	30 Jun 2022	13F
CHI Advisors LLC	13F	Company	1.6%	2,829,712	$7,499,000	—	30 Jun 2022	13F
Avidity Partners Management LP	13F	Company	1.1%	2,000,000	$5,300,000	—	30 Jun 2022	13F
Vivo Capital, LLC	13F	Company	1.1%	2,000,000	$5,300,000	—	30 Jun 2022	13F
Consonance Capital Management LP	13F	Company	0.89%	1,603,789	$4,218,000	—	30 Jun 2022	13F
Foresite Capital Opportunity Management V, LLC	13F	Company	0.86%	1,554,250	$4,119,000	—	30 Jun 2022	13F
Blackstone Inc.	13F	Company	0.84%	1,505,738	$3,990,000	—	30 Jun 2022	13F
VANGUARD GROUP INC	13F	Company	0.83%	1,501,973	$3,980,000	—	30 Jun 2022	13F
Monashee Investment Management LLC	13F	Company	0.68%	1,230,441	$3,261,000	—	30 Jun 2022	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.34%	608,536	$1,613,000	—	30 Jun 2022	13F
DAFNA Capital Management LLC	13F	Company	0.11%	198,094	$525,000	—	30 Jun 2022	13F
BlackRock Finance, Inc.	13F	Company	0.09%	163,426	$433,000	—	30 Jun 2022	13F
LMR Partners LLP	13F	Company	0.06%	100,000	$265,000	—	30 Jun 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.04%	66,165	$175,000	—	30 Jun 2022	13F
CM Management, LLC	13F	Company	0.02%	30,000	$80,000	—	30 Jun 2022	13F
SALEM INVESTMENT COUNSELORS INC	13F	Company	0.02%	30,000	$80,000	—	30 Jun 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.02%	27,861	$74,000	—	30 Jun 2022	13F
New Capital Management LP	13F	Company	0.01%	24,243	$69,000	—	30 Jun 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.01%	24,857	$65,000	—	30 Jun 2022	13F
MARSHALL WACE, LLP	13F	Company	0.01%	23,727	$63,000	—	30 Jun 2022	13F
Mascoma Wealth Management LLC	13F	Company	0.01%	15,682	$42,000	—	30 Jun 2022	13F
B. Riley Wealth Management, Inc.	13F	Company	0.01%	14,918	$40,000	—	30 Jun 2022	13F
FLAGSHIP HARBOR ADVISORS, LLC	13F	Company	0.01%	14,000	$37,000	—	30 Jun 2022	13F
UBS Group AG	13F	Company	0%	7,228	$19,000	—	30 Jun 2022	13F
Charter Oak Capital Management, LLC	13F	Company	0%	1,483	$4,000	—	30 Jun 2022	13F
CITIGROUP INC	13F	Company	0%	1,370	$4,000	—	30 Jun 2022	13F
MORGAN STANLEY	13F	Company	0%	610	$2,000	—	30 Jun 2022	13F
ROYAL BANK OF CANADA	13F	Company	0%	228	$1,000	—	30 Jun 2022	13F
Miranda Jayne Toledano	3/4/5	Director	— mixed-class rows	1,841,549 mixed-class rows	—	—	25 Jun 2021	3/4/5
Susan Kalled	3/4/5	Chief Scientific Officer	— class O/S missing	60,000	—	—	18 Feb 2022	3/4/5
Brett Kaplan	3/4/5	Director	— class O/S missing	30,000	—	—	18 Feb 2022	3/4/5
Stephen P. Squinto	3/4/5	Director	— class O/S missing	30,000	—	—	18 Feb 2022	3/4/5

Institutional Holders of Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX) as of Q3 2022

As of 30 Sep 2022, Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 63,858,418 shares. The largest 10 holders included ORBIMED ADVISORS LLC, FMR LLC, Rock Springs Capital Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Foresite Capital Management V, LLC, JANUS HENDERSON GROUP PLC, CHI Advisors LLC, VANGUARD GROUP INC, Vivo Capital, LLC, and Avidity Partners Management LP. This page lists 36 institutional shareholders reporting positions in this security for the Q3 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

Q3 2022 holders

Holder diff

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 Value $	Q3 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.